Globalepolicy.org is a free to access global medical news service for the consumer, professional and researcher.
Our adviser: Drugs Infromation online
Background: A treatment algorithm and screening examination have been developed to guide patient management and prospectively determine potential for highly active individuals to succeed with nonoperative care after anterior cruciate ligament rupture.
Objective: To prospectively characterize and classify the entire population of highly active individuals over a 10-year period and provide final outcomes for individuals who elected nonoperative care.
Methods: Inclusion criteria included presentation within 7 months of the index injury and an International Knee Documentation Committee level I or II activity level before injury. Concomitant injury, unresolved impairments, and a screening examination were used as criteria to guide management and classify individuals as noncopers (poor potential) or potential copers (good potential) for nonoperative care.
Results: A total of 832 highly active patients with subacute anterior cruciate ligament tears were seen over the 10-year period; 315 had concomitant injuries, 87 had unresolved impairments, and 85 did not participate in the classification algorithm. The remaining 345 patients (216 men, 129 women) participated in the screening examination a mean of 6 weeks after the index injury. There were 199 subjects classified as noncopers and 146 as potential copers. Sixty-three of 88 potential copers successfully returned to preinjury activities without surgery, with 25 of these patients not undergoing anterior cruciate ligament reconstruction at the time of follow-up.
Conclusion: The classification algorithm is an effective tool for prospectively identifying individuals early after anterior cruciate ligament injury who want to pursue nonoperative care or must delay surgical intervention and have good potential to do so.
NAVIGATION
BIOTRONIK SE & Co. KG announced the start of the NORDIC ICD clinical trial. The first implantable cardioverter defibrillator (ICD) patients were enrolled by its coordinating clinical investigator, Prof. Dr. Dietmar Bansch at the University Hospital of Rostock and the investigator Dr. Stefan Kuster at the DRK Hospital of Molln/Ratzeburg…
|
28
Feb |
Medtronic Announces Purchase Of Innovative Gel Technology For Potential Use In Functional Endoscopic Sinus Surgery (FESS)Category: Medical Devices / Diagnostics | Leave a Comment |
Medtronic, Inc. (NYSE: MDT) announced that it has completed the purchase of rights to a chitosan-dextran gel technology from Adelaide Research & Innovation Pty Ltd. (the commercial development company of the University of Adelaide) in Australia, Robinson Squidgel Ltd., and Otago Innovation Ltd. (a University of Otago company) in New Zealand…
|
28
Feb |
Aggressive Type Of Lung Cancer In Never-Smokers Identified By Quick, Easy TestCategory: Lung Cancer | Leave a Comment |
An inexpensive and rapid testing method can effectively identify a sub-group of never-smoking lung cancer patients whose tumors express a molecule associated with increased risk of disease progression or recurrence, US researchers have found…
|
28
Feb |
Inselspital In Bern Begins Advanced Radiotherapy Treatments Using TrueBeam System From Varian Medical SystemsCategory: Radiology / Nuclear Medicine | Leave a Comment |
A leading Swiss cancer clinic has begun delivering advanced radiotherapy treatments using the TrueBeam™ system from Varian Medical Systems (NYSE: VAR). More than 40 patients have been treated using the new system for fast, precise radiotherapy and radiosurgery since clinical treatments began at Inselspital, the university hospital of Bern, the capital of Switzerland…
|
28
Feb |
More Than 4,000 Components Of Blood Chemistry Listed By ResearcherCategory: Blood / Hematology | Leave a Comment |
After three years of exhaustive analysis led by a University of Alberta researcher, the list of known compounds in human blood has exploded from just a handful to more than 4,000. “Right now a medical doctor analyzing the blood of an ailing patient looks at something like 10 to 20 chemicals,” said U of A biochemist David Wishart…
|
27
Feb |
Medicare Continues To Impose Conditions When Covering New TechnologiesCategory: Medicare / Medicaid / SCHIP | Leave a Comment |
The Centers for Medicare and Medicaid Services (CMS), the government agency that administers the Medicare program, made 11 National Coverage Determinations (NCDs) for medical technologies and procedures in 2010. NCDs permit or prohibit Medicare coverage for new technologies on a nationwide basis…
|
26
Feb |
University Of Nevada, Reno Teams With IMMY To Make New Life-Saving Blood TestCategory: Blood / Hematology | Leave a Comment |
A new, rapid blood test that could lead to early diagnosis and potentially save the lives of hundreds of thousands of people stricken with fungal meningitis, a leading cause of AIDS-related deaths in developing countries, is getting closer to market with a recent collaboration between the University of Nevada, Reno and Immuno-Mycologics (IMMY) in Oklahoma…
|
26
Feb |
Trial For New Device Aimed At Treating Patients With Refractory Angina Starts Off WellCategory: Cardiovascular / Cardiology | Leave a Comment |
A team of cardiologists from the Montreal Heart Institute (MHI) have recently started enrolling patients for the Neovasc ReducerTM, designed to treat patients with refractory angina…
|
26
Feb |
Simple Home Urine Test Measures Insulin Production In Diabetes PatientsCategory: Diabetes | Leave a Comment |
A single home urine test which can be sent by post may replace multiple blood tests in hospital - the test measures whether or how much insulin is being produced by individuals with diabetes Type 1 and Type 2. The test kit was developed by Professor Andrew Hattersley and team from the The Peninsula College of Medicine and Dentistry, Exeter, England…
|
25
Feb |
Pivotal Study Validates Roche’s Cobas® HPV Test With HPV-16 And 18 Genotyping For Identifying Women At Highest Risk For Cervical CancerCategory: Cervical Cancer / HPV Vaccine | Leave a Comment |
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that a study published online in the American Journal of Clinical Pathology demonstrated the ability of the cobas HPV Test to individually detect HPV-16 and HPV-18, two of the highest risk HPV genotypes causing 70 percent of cervical cancer cases…